Dr Andrea Jane Kinnan, MD | |
4220 L St, Omaha, NE 68107-1048 | |
(402) 733-4433 | |
(402) 733-1220 |
Full Name | Dr Andrea Jane Kinnan |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 7 Years |
Location | 4220 L St, Omaha, Nebraska |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689014912 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 7071 (Nebraska) | Secondary |
207V00000X | Obstetrics & Gynecology | 30134 (Nebraska) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Central Maine Medical Center | Lewiston, ME | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Alegent Creighton Clinic | 1951210418 | 827 |
News Archive
The environmental concern is great when considering the role of toxic contaminants in the plant-soil relationship. Understanding plant's absorption and accumulation of these contaminants from the soil would be incredibly beneficial.
And in this political climate, the $210 billion price tag [to fix the physician payment system] will probably prevent a permanent solution this year. However, a longer term, interim fix and a primary care payment differential would be steps in the right direction (Dennis Mayeaux and Lori Parham, 9/13).
Setting the stage for another legislative battle that puts mental health patients in the middle, a bill seeking to give licensed psychologists prescribing privileges for dangerous medications is scheduled to be heard on April 23, 2007 in the Senate Business, Professions and Economic Development Committee.
Pregnant women who are stressed, particularly late in pregnancy, have an increased risk of their child going on to develop asthma, according to the latest research from Children of the 90s.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that additional data from a Phase 1 safety and proof-of-concept study evaluating lead candidate, galeterone, in patients with castration-resistant prostate cancer (CRPC) will be highlighted in a poster presentation titled, "Phase I clinical trial of galeterone, a multifunctional anti-androgen and CYP17 inhibitor in castration resistant prostate cancer," abstract number 4665, on Sunday, June 3, 2012, 8:00 a.m. to 12:00 p.m. at the 2012 Annual Meeting of the American Society of Clinical Oncology.
› Verified 3 days ago
Entity Name | Alegent Creighton Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548287907 PECOS PAC ID: 1951210418 Enrollment ID: O20040407001314 |
News Archive
The environmental concern is great when considering the role of toxic contaminants in the plant-soil relationship. Understanding plant's absorption and accumulation of these contaminants from the soil would be incredibly beneficial.
And in this political climate, the $210 billion price tag [to fix the physician payment system] will probably prevent a permanent solution this year. However, a longer term, interim fix and a primary care payment differential would be steps in the right direction (Dennis Mayeaux and Lori Parham, 9/13).
Setting the stage for another legislative battle that puts mental health patients in the middle, a bill seeking to give licensed psychologists prescribing privileges for dangerous medications is scheduled to be heard on April 23, 2007 in the Senate Business, Professions and Economic Development Committee.
Pregnant women who are stressed, particularly late in pregnancy, have an increased risk of their child going on to develop asthma, according to the latest research from Children of the 90s.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that additional data from a Phase 1 safety and proof-of-concept study evaluating lead candidate, galeterone, in patients with castration-resistant prostate cancer (CRPC) will be highlighted in a poster presentation titled, "Phase I clinical trial of galeterone, a multifunctional anti-androgen and CYP17 inhibitor in castration resistant prostate cancer," abstract number 4665, on Sunday, June 3, 2012, 8:00 a.m. to 12:00 p.m. at the 2012 Annual Meeting of the American Society of Clinical Oncology.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Andrea Jane Kinnan, MD 7261 Mercy Rd, Omaha, NE 68124-2311 Ph: (402) 733-4433 | Dr Andrea Jane Kinnan, MD 4220 L St, Omaha, NE 68107-1048 Ph: (402) 733-4433 |
News Archive
The environmental concern is great when considering the role of toxic contaminants in the plant-soil relationship. Understanding plant's absorption and accumulation of these contaminants from the soil would be incredibly beneficial.
And in this political climate, the $210 billion price tag [to fix the physician payment system] will probably prevent a permanent solution this year. However, a longer term, interim fix and a primary care payment differential would be steps in the right direction (Dennis Mayeaux and Lori Parham, 9/13).
Setting the stage for another legislative battle that puts mental health patients in the middle, a bill seeking to give licensed psychologists prescribing privileges for dangerous medications is scheduled to be heard on April 23, 2007 in the Senate Business, Professions and Economic Development Committee.
Pregnant women who are stressed, particularly late in pregnancy, have an increased risk of their child going on to develop asthma, according to the latest research from Children of the 90s.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that additional data from a Phase 1 safety and proof-of-concept study evaluating lead candidate, galeterone, in patients with castration-resistant prostate cancer (CRPC) will be highlighted in a poster presentation titled, "Phase I clinical trial of galeterone, a multifunctional anti-androgen and CYP17 inhibitor in castration resistant prostate cancer," abstract number 4665, on Sunday, June 3, 2012, 8:00 a.m. to 12:00 p.m. at the 2012 Annual Meeting of the American Society of Clinical Oncology.
› Verified 3 days ago
Dr. Elizabeth Stephens Constance, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 7308 S 142nd St, Omaha, NE 68138 Phone: 402-717-4200 | |
Jennifer Marie Burgart, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7710 Mercy Rd Ste 202, Omaha, NE 68124 Phone: 402-280-4438 | |
Dr. Grace Binter, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 983255 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-6160 | |
Dr. Stephanie Lynn Fisher Gustin, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7308 S 142nd St, Omaha, NE 68138 Phone: 402-717-4200 Fax: 402-717-4231 | |
Dr. Alex Keith Laudenklos, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 601 N 30th St, Cu Department Of Obstetrics And Gynecology, Omaha, NE 68131 Phone: 402-717-0947 | |
Mr. Kent Harry Siemers, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7205 W Center Rd, Suite 200, Omaha, NE 68124 Phone: 402-397-6600 Fax: 402-397-8318 | |
Dr. Brent Jonathan Tierney, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Suite 300, Omaha, NE 68114 Phone: 402-354-5250 Fax: 402-354-3437 |